AR

Abdul Rahman Zargar

Director Director DIN 02259131
DIN 02259131 First appointment Oct 2008 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2008
Shareholding value Locked Premium profile

About Abdul Rahman Zargar

Abdul Rahman Zargar has 17 years in corporate governance. Formerly with 1 company, such as Myopics Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02259131
Primary Designation Director
First Appointment 16 Oct 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 16 Oct 2008 2008 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Myopics Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdul Rahman Zargar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Rahman Zargar

Abdul Rahman Zargar has 17 years in corporate governance. Formerly with 1 company, such as Myopics Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Abdul Rahman Zargar is associated with 0 companies as a director.

Abdul Rahman Zargar has expertise in General Business.

Abdul Rahman Zargar has 17 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available